Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers generate feline embryonic stem cells
Scientists had previously developed iPS cells, but this is the first time that ESCs have been generated.
Findings could advance regenerative medicine and conservation.

Researchers have succeeded in generating three lines of feline embryonic stem cells (ESCs).

The pioneering study is expected to have benefits for the advancement of feline regenerative medicine, helping both domesticated and wild cats.

ESCs are considered to be key to veterinary regenerative medicine, largely due to their ability to differentiate into various types of cells and be transplanted to heal internal damage. They are also in a near-natural state, similar to induced pluripotent stem (iPS) cells.

However, while feline iPS cells have previously successfully been generated, researchers had never been able to generate ESCs.

The team, from Osaka Metropolitan University, were able to generate the ESCs using lab-grown blastocysts. Scientists performed in vitro fertilisation of feline sperm and oocytes, which had been taken from discarded reproductive organs after sterilisation surgeries.

By isolating the inner cell mass from blastocyst stage embryos, and then culturing them, the researchers successfully generated high-quality feline ESCs. These ESCs can be maintained in an undifferentiated state, before being differentiated into one of three germ layers: endoderm, ectoderm and mesoderm.

This advancement of feline ESC research is expected to support the treatment of intractable diseases, such as chronic kidney disease.

These cells derived from domestic cats are often being used for research into artificial reproductive technologies (ART) for endangered wild cats. These ESCs could be used to create a supply of germ cells for ART research, tackling the germ cell shortage among wild felines.

As well as their benefits for regenerative medicine, ESCs are also beneficial for drug discoveries and in vitro organogenesis studies. Research into feline ESCs may even contribute to the development of regenerative medicine for humans.

Shingo Hatoya, who led the study, said: "Embryonic stem cells are pluripotent cells, so we believe that comparative studies with iPS cells will further promote veterinary regenerative medicine research,

"The successful establishment of feline ES cells in this study can advance veterinary regenerative medicine by enabling comparative studies with feline iPS cells. Moreover, the potential to derive sperm and oocytes from feline ES cells could contribute to the conservation of endangered wild cat species."

The full study can be found in the journal Regenerative Therapy.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

RCVS renewal fees increase by four per cent

News Story 1
 The Royal College of Veterinary Surgeons (RCVS) has announced a four per cent increase to its annual renewal fees.

RCVS treasurer Tshidi Gardiner said that the council had tried to keep the fees to a minimum, while increasing the fees in line with inflation. It is a two per cent lower increase than in 2024.

Fee notices will be sent to veterinary surgeons within the first two weeks of March, who will have until 1 April to pay for their annual renewal.

Veterinary surgeons who do not pay their fee before 1 May will incur a higher fee of £36. Non-payment by 1 June could mean they are removed from the RCVS register.

The veterinary nurse annual renewal period, taking place in autumn, will see the same percentage increase. 

Click here for more...
News Shorts
Wales licenses Bluetongue vaccines for voluntary use

The Welsh government has approved three Bluetongue vaccines for emergency use in Wales.

From 1 March an online general licence will become available for the vaccines' use. They will then be obtainable on prescription and can be sold by veterinary practices.

After appropriate guidance, livestock keepers will be permitted to administer the vaccines themselves. The vaccines must be prescribed by a veterinary surgeon and detailed vaccination records must be kept for five years.

The decision comes as Bluetongue virus (BTV-3) continues to spread across England. The three vaccines are already licensed for use in England.

Richard Irvine, CVO for Wales, said: "This decision to licence these vaccines was informed by our recent risk assessment indicating that Wales is now at high risk of experiencing an incursion of Bluetongue this year.

"Our primary aim is to keep Bluetongue out of Wales through biosecurity, vigilance and safe sourcing of livestock."